ii pharmaceuticals in the Delta is possible, however the updated model results significantly underestimates the concentrations found in some portions of the Delta. The monitoring data collected by the National Water Research Institute and United States Geological Survey were more consistent with the original model results than with the updated calculated concentrations. Additional data on the presence of these and other PPCPs in the Delta might help clarify this discrepancy and could be used to calibrate and validate future models.
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INTRODUCTION
Pharmaceuticals and personal care products (PPCPs) are recognized water pollutants and can be found at trace levels in surface water and groundwater around the world Kolpin et al. 2002; Petrović 2007) . Adverse effects from endocrine disruption and other biochemical pathways on a variety of aquatic organisms have been demonstrated, and examples include feminization of fish, deformities in amphipod crustaceans, reduced biomass and diversity in algal populations, and altered behavior in fish and tadpoles Fraker and Smith 2004; Henry and Black 2008; Kidd et al. 2007; Routledge 2 et al. 1998; Vandenbergh et al. 2003; Wilson et al. 2003) . PPCPs are present in drinking water although the effects on human health are unknown . Despite thousands of studies, including those on complex mixtures of PPCP compounds, determining whether PPCPs in surface water represent a significant environmental problem is unclear.
Wastewater treatment plant (WWTP) effluent is the most significant environmental source of PPCPs Petrović and Barceló 2007) . After consumption or use, PPCP compounds and metabolites are excreted through urine and feces or washed from the body and released into wastewater streams and septic systems . In addition to excretion, PPCPs are directly disposed of into home plumbing systems. The relative contributions of excretion and disposal are unknown although it is expected that the contribution from disposal is relatively minor (Heberer 2002) . Existing wastewater treatment systems were not designed to remove the compounds found in PPCPs and a costeffective treatment option is not currently available Ternes 1999) . However, wastewater treatment processes reduce the concentrations of many PPCPs to varying degrees (Petrović and Barceló 2007) . Therefore, PPCPs remaining after wastewater treatment are the contaminants in question. Currently, PPCPs are not regulated as water contaminants by the federal or California state governments.
Several WWTPs discharge into the Sacramento-San Joaquin Delta (Delta), which is a unique aquatic ecosystem, a source of drinking water for over 25 million Californians, and a primary source of water for Central Valley agriculture. The health of the Delta ecosystem has been in steady decline for many years as a result of multiple stressors, including large-scale drinking water exports via the State Water Project (SWP) and Central Valley Project (CVP), contaminants in agricultural and urban runoff, power plant diversions, invasive species, municipal wastewater and industrial discharges, and highly regulated tributary river systems (CALFED 2008) . Given the large population that is served by numerous WWTPs that discharge to the Delta, it is possible that PPCPs are another important stressor that contributes to this ecosystem decline.
Data on the presence of PPCPs in the Delta are very limited. None of the ongoing monitoring programs in the Delta include PPCPs. Occurrence data consist of results from a few short-term studies. A variety of PPCPs-including antibiotics, steroid hormones, caffeine, antidepressants, lipid regulators, antihypertensives, anticoagulants, and other compounds-were detected in Delta waters during these studies (Guo et al. 2010; Kolpin et al. 2002; Oros et al. 2003) . A 2006 study evaluated water from 16 sites within the Delta and Napa River for the presence of steroid hormones and evidence of endocrine disruption by completing chemical analyses and bioassays on rainbow trout (Oncorhynchus mykiss). Natural and synthetic steroid hormones were either not present in the samples or were in concentrations that were below quantification limits. In contrast, high estrogenic activity was found in the bioassay results at 6 of the 16 sites. The inconsistency between the chemical and bioassay results was attributed to the possibility that other compounds could be responsible for the observed estrogenicity in rainbow trout (Lavado et al. 2008) . Another study demonstrated a higher frequency of feminization of fall-run chinook salmon (Oncorhynchus tshawytscha) from the Sacramento and San Joaquin river basins when compared to hatchery populations (Williamson and May 2002) . Though the issue of PPCPs in the Delta has received very little attention to date, especially when considering the immense efforts that are underway to understand and manage the Delta as a viable ecosystem and water source, the few studies that have been conducted suggest PPCPs cannot be eliminated as an important stressor of the Delta ecosystem and that they are possibly relevant to human health. However, the distribution and fate of these compounds remains unclear.
The purpose of this study was to address whether PPCP releases from WWTPs in the Delta watershed could result in regional contamination, and to estimate the approximate (order of magnitude) concentrations at which such contamination might be found. This was accomplished by: (1) 
METHODS

Sacramento River Sampling
Using passive sampling devices we monitored four sites for 30 PPCPs within the Sacramento River near the effluent of the Sacramento Regional Wastewater Treatment Plant (SRWTP). The location of each monitoring site and the regional setting of the monitoring study area are provided in Figure 1 . One monitoring site was located upstream and three sites were downstream of the SRWTP efflu- Passive sampling devices used in this study included three POCIS and SMPDs at each monitoring location. The POCIS membranes are designed to sequester hydrophilic polar organic compounds while the SPMD membranes trap hydrophobic compounds MacLeod et al. 2007 ). Most PPCPs are polar organic compounds (Petrović and Barceló 2007) . Both types of sampling devices were used to be thorough and because surfactants and musks, which exhibit hydrophobicity, were included as analytes. See Appendix A for detail on passive sampler deployment.
Passive sampler membrane extract was screened for 30 analytes including the antibiotics carbadox, chlorotetracycline, doxycycline, lincomycin, oxytetracycline, roxithromycin, sulfadimethoxine, sulfachloropyridazine, sulfamerazine, sulfamethazine, sulfathiazole, sulfamethizole, sulfamethoxazole, tetracycline, trimethoprim, and tylosin; erythromycin hydrate (antibiotic metabolite); caffeine (stimulant); gemfibrozil (lipid regulator); ibuprofen (non-steroidal antiinflammatory); triclosan (antibacterial); 17β-estradiol (natural estrogen hormone); carbamazepine (antiionization (API-ES) source in positive and negative ion modes. Method detection limits ranged from 2 to 50 ng L -1 . We analyzed surfactants by using highperformance liquid chromatography with a fluorescence detector and confirmed it with a liquid chromatography mass detector operated in negative and positive mode for nonylphenol and nonyphenol ethoxylate, respectively. The reporting limit is 20 ng L -1 . Analysis for musks followed the EPA Method 8270 M. We analyzed the POCIS extract for musks by gas chromatography with a Mass Spectrometer Ion Trap Detector (operated in MS/MS mode). We analyzed the SPMD extract musks in the same manner as we did for pharmaceutical analytes.
Analytical results from passive sampling devices were reported in terms of mass per membrane filter. Empirically-determined, compound-specific linear uptake sampling rates, where available, were used to calculate an average concentration applicable to the river water over the monitoring period. Sampling rates have been determined for carbamazepine, fluoxetine, gemfibrozil, and trimethoprim and were used to calculate average concentrations for each compound at each monitoring site (MacLeod et al. 2007 ) (Table 1) . Where sampling rates were not available, results are presented in ng per membrane (complete analytical results provided in Appendix A). None of the analytes were detected in the SPMD extract and, therefore, information on sampling rates focuses on the POCIS membranes. Analyte uptake by the POCIS devices is governed by analyte diffusion through the aqueous boundary layer that surrounds the membrane, and is independent of concentration in the sampled water body ). Equation 1 developed by Huckins et al. (2000) relates the sampling rate (R S ); concentrations in water (C W ) and sorbent (C S ) (MacLeod et al. 2007); mass of the membrane (Williamson and May 2002) ; and time in situ in days (t) and is appropriate for POCIS and SPMDs Huckins et al. 2000) . The mass of a POCIS membrane is 228 mg and the sampling time is 33 days.
Transport Modeling
Carbamazepine, fluoxetine, and trimethoprim were selected from the list of detected analytes for use in the transport model. We selected these compounds because they have published POCIS sampling rates and are frequently detected in PPCP monitoring studies (Kolpin et al. 2002; Petrović and Barceló 2007) . Decay rates 0.011 day -1 , 0.033 day -1 , 0.017 day -1 were applied to the transport of carbamazepine, fluoxetine, and trimethoprim, respectively. Corresponding half-lives are 63, 21, and 42 days, respectively. We developed decay rates for each modeled pharmaceutical based on existing fate and monitoring studies. The basis for the selection of specific decay rates is provided in Appendix A. Dilution, advection, direct and indirect photolysis, adsorption to sediment, biodegradation, and bioaccumulation act on PPCPs in surface water (Petrović and Barceló 2007) . Therefore, a decay rate that represents the cumulative effect of these processes is a critical model parameter. It is important to note that each of the processes listed above are relevant at different time-scales and vary in importance by the PPCP compound in question, as well as the character of the receiving water body. Dilution and advection are important in the transport of any compound found in WWTP effluent, and generally result in a reduction in concentration with distance from the point of discharge. Exceptions have been found in small systems where low or slow moving flow resulted in virtually no dilution downstream of the point of discharge (Petrović and Barceló 2007) . Given that the receiving water bodies considered in this study vary in character, we recognize that the application of one decay rate for each modeled compound is a potential oversimplification of these local systems within the Delta.
We used the RMA Delta Model to analyze the movement of carbamazepine, fluoxetine, and trimethoprim through the Delta. The RMA Delta Model is a 2-D, depth averaged, finite element, hydrodynamic (RMA2) and water quality (RMA11) numerical model specific to the Delta. In the finite element grid, the Delta is represented through 2D quadrilaterals and triangles and one-dimensional (1-D) river and channel reaches that include the Delta as legally defined in the California Water Code Section 12220 as well as Suisun Bay, sloughs and creeks that surround Suisun Marsh, Honker Bay, Grizzly Bay, and the Carquinez Strait (CA Water Code Section 12220). Elements range in size from 10 to 100 m on any side.
The RMA2 portion of the model is applicable to farfield problems for vertically homogenous fluids with a free surface. The program computes water surface elevations, or stage, and horizontal velocity by the Bubnov-Galerkin finite element approximation for spatial derivatives and a modified Crank-Nicholson for time derivatives using the momentum equation in the x and y direction and the continuity equation, shown as Equations 2 through 4 below, respectively. RMA2 was developed in 1973 and has been continually improved and calibrated by RMA, the Coastal and Hydraulics Laboratory at the U.S. Army Corps of Engineers' Engineer Research and Development Center, and others. The RMA Delta model is highly calibrated and frequently used to study flooding, seal level rise, reservoir and gate operations, water supply export strategies, water quality, and other topics in the Delta (King 1998; King and Norton 1978; King and Rachiele 1990) .
Variables in Equations 2 through 5 are: x,y = horizontal Cartesian coordinates; t = time; u,v = horizontal velocity components; h = depth; a = bottom elevation; εxx, εxy, εyx, εyy = turbulent eddy coefficients; g = acceleration due to gravity; C = Chezy bottom friction coefficient in Equations 2 through 4 and constituent concentration in Equation 5; V = total water velocity; q s = tributary flow; Ωvh, Ωuh = coriolis forcing; Wx, Wy = wind stress; q1 = inflow per unit area; Dx, Dxy, Dy = diffusion coefficients; R = growth rate; θs = source rate = -kC, and k is the decay rate. Each pharmaceutical was defined as an arbitrary constituent subject to first order kinetics in RMA11.
The RMA11 water quality model uses the RMA2 velocity and stage output and the following equation to calculate steady-state transport.
Inputs from all WWTPs that discharge to areas included in the RMA Delta Model finite element grid were considered in the analysis. The WWTPs included Delta Diablo, Discovery Bay, Fairfield, Mountain House, Rio Vista Beach, Rio Vista Northwest, Sacramento Regional, Stockton, Tracy, and White Slough (City of Lodi) ( Figure 1 ). The SRWTP treats wastewater generated by a residential population of 1.3 million, in addition to that generated by commercial and industrial customers within a 368-mi 2 area. According to the 2020 Master Plan for the facility, in the year 2000, average flows were approximately 154 million gallons per day (mgd) (SRCSD 2008) . It is assumed that the communities served by the ten WWTPs included in this study do not differ significantly in their access to medical treatment, prescription drugs, or personal care products and, thus, were considered spatially and temporally uniform in terms of general PPCP consumption and use of the three compounds considered in the model. Even if it is assumed that the populations served by the WWTPs do not vary in terms of access to PPCPs, it is expected that actual concentrations in the effluent of the WWTPs included in this study would vary because level of treatment and treatment methods differ among WWTPs. Several chemical and physical characteristics of each class of compounds determine the degree to which a specific treatment technology is effective. The actual concentrations of PPCPs in the WWTP effluent could vary by up to two orders of magnitude (Petrović and Barceló 2007) .
We considered effluent inputs from each WWTP to be proportional to those from the SRWTP, and calculated the inputs for each pharmaceutical using the concentrations determined from the POCIS sampling of the Sacramento River and the effluent flow time series from each WWTP. We generated time series We assumed initial PPCP concentrations to be zero with a 2-month spin-up with inputs beginning in August, or 2 months before the start of the water year. We modeled the 2006, 2007, and 2009 water years so that a recent wet and dry year (2006 and 2007, respectively) were modeled along with the water year from which the PPCP concentrations were monitored (2009). Forty-five locations throughout the grid were selected as stations for model output; these included locations commonly monitored as part of various water quality programs in the Delta and sites where data were available to validate the model (Figure 1, Appendix A) . Developers of the RMA Delta Model have determined that the most appropriate time step for the system is 7.5 min, and we used this time step in each model run.
RESULTS AND DISCUSSION
Sacramento River Sampling
Caffeine, trimethoprim, sulfamethoxazole, gemfibrozil, fluoxetine, ibuprofen, carbamazepine, xylene, nonylphenol, and nonylphenol ethoxylates were detected at one or more monitoring site (complete 
Transport Modeling
Results include the average monthly concentrations at each location for the months of October, January, April, and July of each simulated water year (see Tables 2 through 4 in Appendix A). Model results included the presence of all three pharmaceuticals throughout the year at concentrations 
Results include the average monthly concentrations at each location for the months of October, January, April, and July of each simulated water year (see Tables 2 through 4 in Appendix A). Model results included the presence of all three pharmaceuticals throughout the year at concentrations below 0.06 ng L -1 at nearly all output points. The maximum calculated concentration for all three pharmaceuticals occurred at the Stockton Ship Channel at Burns Cutoff output location and the January 2009 time period. Maximum calculated concentrations of carbamazepine, fluoxetine, and trimethoprim were 0.06, 0.04, and 0.05 ng L -1 , respectively. The WWTP discharge data available for model input was limited to a monthly time step and, therefore, any diurnal variation was not captured in the model. The calculated concentrations of all three pharmaceuticals were consistently above zero throughout the Delta, and did not fluctuate widely. 
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Mossdale were compared to model results (Figure 2) . The monitoring results included concentrations of carbamazepine in April, July, and October 2008 and January 2009. The level of agreement between these data and the model results varies. Of the sixteen comparisons shown in Figure 2 , three vary by less than 25%, 8 vary by less than 50% and six vary by more than 75%, including all four comparisons at the San Joaquin River at Mossdale. This variability in the level of agreement underscores the need for an understanding of the how concentrations of PPCP compounds in WWTP discharges to the Delta may differ.
The model results can also be compared to a national reconnaissance study conducted by the United (Kolpin et al. 2002) . Fluoxetine concentrations were estimated in the USGS study because of an average recovery of less than 60% in the laboratory. The estimated maximum concentration at all four sites was 12 ng L -1 . Carbamazepine and trimethoprim were not included in the list of analytes in the USGS study. While the model results indicate that carbamazepine, fluoxetine, and trimethoprim are persistent throughout the year in the Delta at low ng L -1 concentrations, addi- 
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The model results can also be compared to a national reconnaissance study conducted by the United States Geological Survey (USGS) in 1999 to 2000. Among the 139 sites included in the USGS study, one site (Sacramento River at Freeport) was within the Delta, and four sites (Mud Slough near Gustine, Orestimba Creek near Crows Landing, San Joaquin River near Vernalis, and French Camp Slough near Stockton) were tributary to the Delta (Kolpin et al. 2002) . Fluoxetine concentrations were estimated in the USGS study because of an average recovery of less than 60% in the laboratory. The estimated maximum concentration at all four sites was 12 ng L -1 . Carbamazepine and trimethoprim were not included in the list of analytes in the USGS study. While the model results indicate that carbamazepine, fluoxetine, and trimethoprim are persistent throughout the year in the Delta at low ng L -1 concentrations, addi- 
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Mossdale were compared to model results ( Table 2) . The NWRI monitoring results included concentrations of carbamazepine in April, July, and October 2008 and January 2009. This large difference between the modeled and monitored results underscores the need for an understanding of how the concentrations of PPCP compounds in WWTP discharges to the Delta may differ.
The model results can also be compared to a national reconnaissance study conducted by the United States Geological Survey (USGS) in 1999 to 2000. Among the 139 sites included in the USGS study, one site (Sacramento River at Freeport) was within the Delta, and four sites (Mud Slough near Gustine, Orestimba Creek near Crows Landing, San Joaquin River near Vernalis, and French Camp Slough near Stockton) were tributary to the Delta (Kolpin et al. 2002) . Fluoxetine concentrations were estimated in the USGS study because of an average recovery of less than 60% in the laboratory. The estimated maximum concentration at all four sites was 12 ng L -1 . Carbamazepine and trimethoprim were not included in the list of analytes in the USGS study. As with the NWRI data, the model results are significantly lower than the USGS data. Additional data on the presence of these and other PPCPs in the Delta might help clarify this discrepancy and could be used to calibrate and validate future models. 10 tional data on the presence of these and other PPCPs in the Delta is required to more thoroughly calibrate and validate the model.
Ecological Implications
The ecological implications of the presence of carbamazepine, fluoxetine, trimethoprim, and presumably other pharmaceuticals within the Delta are unknown.
Of the three pharmaceuticals analyzed in this study, the toxicity of fluoxetine to aquatic organisms has been the most studied. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). This class of drugs induces an extracellular supply of serotonin, a mood-regulating neurotransmitter and neurohormone (Kreke and Dietrich 2008) . Serotonin is highly conserved and found in vertebrates and invertebrates Kreke and Dietrich 2008) .
Limited research indicates that SSRIs may result in decreased activity in freshwater crustaceans and fish. After exposure to 10 and 100 ng L -1 of fluoxetine, the freshwater crustacean Gammarus pulex exhibited significantly reduced activity while behavior at higher concentrations of 1 µg L -1 to 1 mg L -1 was equivalent to the control population ). Goldfish exposed to 81 µg L -1 of fluoxetine were less active when compared to the control group in a study that evaluated active avoidance learning in the fish . Decreased activity resulting from SSRI exposure could have population-level ecological effects though no studies have investigated the possibility. Studies also indicate that SSRIs and their metabolites may bioaccumulate in fish. Fluoxetine, norfluoxetine, sertraline, and desmethylsertraline were found in brain, liver, and lateral muscle tissues of bluegill (Lepomis macrochirus), channel catfish (Ictalurus punctatus), and black crappie (Pomoxis nigromaculatus) from an effluentdominated stream in Texas ). Brain tissue had the highest concentrations followed by liver and then muscle. The fluoxetine metabolites norfluoxetine and desmethylsertraline were found in higher concentrations than their parent compounds in all tissues of each species, which is consistent with the behavior of SSRIs in human and rat tissues . The ecological implications of SSRIs in fish tissues are unknown.
The effect of carbamazepine and trimethoprim on aquatic organisms is largely unknown. The midge Chironomus riparius was exposed to carbamazepine in sediment at 0.16 to 100 mg kg -1 dry weight. At 70 to 100 µg kg -1 there was a blockage of pupation and emergence (Oetken et al. 2005 ). In the same study, the oligochaete Lumbriculus variegates was exposed to 0.625 to 10 mg kg -1 dry weight in sediment and the freshwater snail Potamopyrgus antipodarum was placed in aqueous concentrations of 0.4 to 250 mg L -1 with no statistically significant adverse effects. Another study found that the composition and function of organisms within riverine biofilm communities were significantly modified after exposure to 10 µg L -1 of carbamazepine with significant reductions in bacterial and cyanobacterial biomass, increases in aerobic heterotrophic bacterial and fungal plate counts, and no impact to algal biomass (Lawrence et al. 2005) . A study evaluating the cytotoxic and oxidative effects of various PPCPs on rainbow trout (Oncorhynchus mykiss) found that carbamazepine may adversely impact liver function (Gagne et al. 2006) . There are no studies of the chronic toxicity of trimethoprim at environmentally relevant concentrations. However, trimethoprim, an antibiotic, inhibits the folate biosynthetic pathway in aquatic plants as it does in bacteria. Folates are required by plants for lignin formation and photorespiration . Trimethoprim caused inhibited growth and ejection of the symbiotic algae within the digestive cells of green hydra in one study (McAuley 1981) . Though it is very difficult to draw meaningful conclusions about the Delta from the effects described above, these studies provide evidence that many parts of the food web, including plants, biofilm, macroinvertibrates, zooplankton, and fish could be adversely affected by one or more of the compounds included in this study, which are three of potentially hundreds or thousands of PPCP compounds present in Delta waters. Though the studies described above give some indication of potential effects on aquatic species and ecosystems, these and other research efforts do not provide a clear picture of the effects these compounds may have at the concentrations estimated and observed in the Delta.
10 tional data on the presence of these and other PPCPs in the Delta is required to more thoroughly calibrate and validate the model.
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tional data on the presence of these and other PPCPs in the Delta is required to more thoroughly calibrate and validate the model. The model results indicate that it is possible that carbamazepine, fluoxetine, and trimethoprim are persistent all year in the Delta at sub ng L -1 concentrations. Previous studies are very few and associated data are limited; however, the results of those efforts also indicate that PPCPs may be present in the Delta at low ng L -1 concentrations. Current understanding about the risks of exposure could be improved with additional data about the occurrence of PPCPs in the Delta, variability of concentrations in effluent from WWTPs that discharge to the Delta, and potential variation in applicable decay rates. Additional fate and transport and focused ecotoxicity studies are also necessary. Passive sampling devices and the RMA Delta Model are useful tools that could support that work. Such studies would be of great value in advancing our understanding of the influence of PPCPs on the health of the Delta ecosystem.
